Masato Katagiri Selected Research

Masato Katagiri Research Topics

Disease

23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 08/2005
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 09/2009
4	Neoplasms (Cancer) 11/2018 - 02/2003
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 01/2015
2	COVID-19 01/2023 - 05/2022
2	Neoplasm Metastasis (Metastasis) 10/2019 - 11/2018
2	Disease Progression 01/2019 - 01/2019
2	Adenocarcinoma of Lung 11/2018 - 03/2010
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 11/2016
2	Diabetes Mellitus 01/2018 - 04/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018 - 03/2010
2	Venous Thromboembolism 01/2018 - 11/2016
2	Hypercapnia 12/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 01/2012 - 12/2008
1	Acute Kidney Injury (Acute Renal Failure) 03/2022
1	Kidney Diseases (Kidney Disease) 03/2022
1	Necrotizing Pneumonia 07/2021
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Radiation Pneumonitis 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Albuminuria 01/2018
1	Infections 08/2015
1	Erysipelas 08/2015
1	Leukopenia 08/2015
1	Eosinophilia 03/2015
1	Asthma (Bronchial Asthma) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Neutropenia 06/2012
1	Carcinoma (Carcinomatosis) 09/2009
1	Hyperglycemia 06/2006

Drug/Important Bio-Agent (IBA)

10	amrubicinIBA 01/2020 - 03/2007
8	ErbB Receptors (EGF Receptor)IBA 01/2020 - 08/2005
5	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2010
5	Gefitinib (Iressa)FDA Link 01/2015 - 08/2005
3	PlatinumIBA 01/2018 - 08/2005
3	Pemetrexed (MTA)FDA Link 01/2016 - 01/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2015 - 03/2010
3	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 03/2007
2	NivolumabIBA 01/2019 - 11/2018
2	osimertinibIBA 01/2019 - 01/2019
2	130-nm albumin-bound paclitaxelIBA 01/2018 - 01/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 01/2018
2	Aminophylline (Carine)FDA LinkGeneric 12/2016 - 01/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2013 - 06/2006
1	Complement System Proteins (Complement)IBA 11/2023
1	Nucleic AcidsIBA 01/2023
1	Ivermectin (Mectizan)FDA Link 01/2023
1	Blood Glucose (Blood Sugar)IBA 05/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2022
1	Glucose (Dextrose)FDA LinkGeneric 05/2022
1	bardoxolone methylIBA 03/2022
1	Panton-Valentine leukocidinIBA 07/2021
1	AfatinibIBA 12/2020
1	durvalumabIBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Carbon MonoxideIBA 12/2018
1	Immune Checkpoint InhibitorsIBA 11/2018
1	B7-H1 AntigenIBA 11/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	CollagenIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 01/2018
1	nedaplatinIBA 01/2018
1	AsbestosIBA 01/2018
1	Immunoglobulin E (IgE)IBA 03/2015
1	Theophylline (Theon)FDA LinkGeneric 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	Enalapril FDA LinkGeneric 04/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 04/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012
1	Topoisomerase II InhibitorsIBA 06/2012
1	Topoisomerase I InhibitorsIBA 06/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	Phosphotransferases (Kinase)IBA 03/2010
1	Warfarin (Coumadin)FDA LinkGeneric 08/2009
1	Peptide Nucleic AcidsIBA 12/2008
1	3-nitrotyrosineIBA 06/2006
1	anilinoquinazolineIBA 08/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2005
1	von Willebrand FactorIBA 02/2003

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2020 - 08/2005
8	Therapeutics 05/2022 - 01/2012
2	Chemoradiotherapy 01/2020 - 07/2017
2	Surgical Casts (Plaster Cast) 01/2018 - 11/2016
1	Drug Tapering 12/2020
1	Immunotherapy 01/2017